Procurement Summary
Country: Argentina
Summary: Tocilizumab Et Al
Deadline: 13 Jul 2026
Posting Date: 07 Jul 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 144692428
Document Ref. No.: 420-0726-CDI26
Competition: NCB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: ARS 106172000.00
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
CASPOFUNGIN 70 mg. Model: Caspofungin Acetate 83.9 mg (equivalent to 75.6 mg of anhydrous free acid), injectable, lyophilized, in a vial, intravenous use, CASPOFUNGIN 50 mg. Model: Caspofungin Acetate 60.6 mg (equivalent to 54.6 free acid anhydrous), injectable, lyophilized, in vial, intravenous use, TOCILIZUMAB. Model: 200 mg/10 ml (20 mg/ml), injectable, in a vial, RASBURICASA Other specifications must be indicated by the requesting department. Model: 1.5 mg/ml. Powder for Injection., C1-ESTERASE INHIBITOR. Model: 500 UP, injectable, lyophilized, in vial, BASILIXIMAB. Model: 20 mg, lyophilized injection + solvent ampoule, ILOPROST. Model: Prostaglandin inhalation, solution for nebulize, in a bottle x 2 ml, EPOPROSTENOL Other specifications must be indicated by the requesting department. Model: 1.5 mg, in blister bottle.
File number: EX-2026-29392254- -GCABA-HGNRG Legal framework: Law N? 2, 095 (Consolidated Text by Law No. 6, 588) and Decree No. 129/23 Art. 29 More info: Place of receipt of physical documentation: GALLO 1330
Documents
Tender Notice